Alpha Teknova, Inc. (TKNO)
USD 5.67
(1.43%)
USD 5.67
(1.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 30.45 Million USD | -28.01% |
| 2022 | 42.31 Million USD | 256.44% |
| 2021 | 11.87 Million USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 45 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 30.97 Million USD | -1.23% |
| 2024 Q1 | 31.36 Million USD | 2.96% |
| 2023 Q1 | 40.91 Million USD | -3.29% |
| 2023 Q3 | 30.81 Million USD | -23.42% |
| 2023 FY | 30.45 Million USD | -28.01% |
| 2023 Q2 | 40.23 Million USD | -1.67% |
| 2023 Q4 | 30.45 Million USD | -1.15% |
| 2022 Q3 | 35.96 Million USD | -1.27% |
| 2022 FY | 42.31 Million USD | 256.44% |
| 2022 Q4 | 42.31 Million USD | 17.66% |
| 2022 Q2 | 36.42 Million USD | 13.99% |
| 2022 Q1 | 31.95 Million USD | 169.18% |
| 2021 FY | 11.87 Million USD | 0.0% |
| 2021 Q3 | 11.82 Million USD | 0.37% |
| 2021 Q2 | 11.78 Million USD | 0.39% |
| 2021 Q1 | 11.73 Million USD | 0.0% |
| 2021 Q4 | 11.87 Million USD | 0.37% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | -100.0% |
| 2019 FY | 45 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 95.483% |
| Embecta Corp. | 1.63 Billion USD | 98.141% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 90.341% |
| Dynavax Technologies Corporation | 256.91 Million USD | 88.145% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 94.37% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 94.803% |
| PainReform Ltd. | 86 Thousand USD | -35316.279% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 69.179% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -4530.952% |
| SCYNEXIS, Inc. | 15.08 Million USD | -101.976% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -1050.463% |
| Cosmos Health Inc. | 12.42 Million USD | -145.155% |
| Journey Medical Corporation | 17.73 Million USD | -71.788% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -4530.952% |
| Safety Shot Inc | 1.54 Million USD | -1866.334% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -79.821% |
| Bright Green Corporation | 1.85 Million USD | -1544.793% |
| Procaps Group, S.A. | 285.93 Million USD | 89.348% |
| Theratechnologies Inc. | 58.96 Million USD | 48.348% |
| Harrow Health, Inc. | 190.5 Million USD | 84.012% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -4909.539% |
| Biofrontera Inc. | 5.39 Million USD | -464.142% |
| DURECT Corporation | 20.74 Million USD | -46.814% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 26.655% |
| Cronos Group Inc. | 2.53 Million USD | -1099.163% |
| OptiNose, Inc. | 131.74 Million USD | 76.882% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 95.743% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 16.147% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -2496.577% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 74.48% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -65.277% |
| Radius Health, Inc. | 365.31 Million USD | 91.662% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -455.554% |
| ProPhase Labs, Inc. | 21.38 Million USD | -42.46% |
| Phibro Animal Health Corporation | 525.45 Million USD | 94.204% |
| Procaps Group S.A. | 285.93 Million USD | 89.348% |
| Alvotech | 1.07 Billion USD | 97.168% |
| TherapeuticsMD, Inc. | 8 Million USD | -280.487% |
| Viatris Inc. | 18.12 Billion USD | 99.832% |
| Rockwell Medical, Inc. | 13.43 Million USD | -126.639% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -101.322% |
| SIGA Technologies, Inc. | 1.46 Million USD | -1980.452% |
| Tilray Brands, Inc. | 387.31 Million USD | 92.136% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 76.635% |
| Shineco, Inc. | 29.65 Million USD | -2.703% |
| PetIQ, Inc. | 468.3 Million USD | 93.496% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -50827.149% |
| Incannex Healthcare Limited | 373 Thousand USD | -8065.684% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 92.89% |
| Alimera Sciences, Inc. | 67.39 Million USD | 54.809% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 40.91 Million USD | 25.552% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -2700.236% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -268.002% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -1359.415% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -2848.171% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 13.922% |
| Hempacco Co., Inc. | 13.72 Million USD | -121.924% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.07 Billion USD | 97.168% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 51.241% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 95.063% |
| Currenc Group, Inc. | 31.94 Million USD | 4.651% |
| Kamada Ltd. | 8.74 Million USD | -248.132% |
| Indivior PLC | 281.6 Million USD | 89.184% |
| Evoke Pharma, Inc. | 5 Million USD | -509.16% |
| Flora Growth Corp. | 3.67 Million USD | -729.466% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -2848.171% |
| Evolus, Inc. | 126.54 Million USD | 75.931% |
| HUTCHMED (China) Limited | 86.13 Million USD | 64.638% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 95.116% |
| Akanda Corp. | 3.99 Million USD | -661.68% |